HUP9903987A2 - Tachikinin-antagonista hatású N-acil-2-szubsztituált-4-(benzimidazolil-vagy imidazo-piridinil-szubsztituált csoport)-piperidin -származékok - Google Patents
Tachikinin-antagonista hatású N-acil-2-szubsztituált-4-(benzimidazolil-vagy imidazo-piridinil-szubsztituált csoport)-piperidin -származékokInfo
- Publication number
- HUP9903987A2 HUP9903987A2 HU9903987A HUP9903987A HUP9903987A2 HU P9903987 A2 HUP9903987 A2 HU P9903987A2 HU 9903987 A HU9903987 A HU 9903987A HU P9903987 A HUP9903987 A HU P9903987A HU P9903987 A2 HUP9903987 A2 HU P9903987A2
- Authority
- HU
- Hungary
- Prior art keywords
- alkyl
- optionally substituted
- halo
- formula
- substituted
- Prior art date
Links
- 102000003141 Tachykinin Human genes 0.000 title 1
- 108060008037 tachykinin Proteins 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 10
- 125000001475 halogen functional group Chemical group 0.000 abstract 7
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 2
- 125000002541 furyl group Chemical group 0.000 abstract 2
- 125000000896 monocarboxylic acid group Chemical group 0.000 abstract 2
- 125000002971 oxazolyl group Chemical group 0.000 abstract 2
- 125000004076 pyridyl group Chemical group 0.000 abstract 2
- 125000000335 thiazolyl group Chemical group 0.000 abstract 2
- 125000001544 thienyl group Chemical group 0.000 abstract 2
- -1 COOT Chemical group 0.000 abstract 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- 150000001204 N-oxides Chemical class 0.000 abstract 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 abstract 1
- 125000004604 benzisothiazolyl group Chemical group S1N=C(C2=C1C=CC=C2)* 0.000 abstract 1
- 125000004603 benzisoxazolyl group Chemical group O1N=C(C2=C1C=CC=C2)* 0.000 abstract 1
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 abstract 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 abstract 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 abstract 1
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000002883 imidazolyl group Chemical group 0.000 abstract 1
- 125000001041 indolyl group Chemical group 0.000 abstract 1
- 125000001786 isothiazolyl group Chemical group 0.000 abstract 1
- 125000000842 isoxazolyl group Chemical group 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 125000003373 pyrazinyl group Chemical group 0.000 abstract 1
- 125000003226 pyrazolyl group Chemical group 0.000 abstract 1
- 125000002098 pyridazinyl group Chemical group 0.000 abstract 1
- 125000000714 pyrimidinyl group Chemical group 0.000 abstract 1
- 125000000168 pyrrolyl group Chemical group 0.000 abstract 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 abstract 1
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Virology (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Rheumatology (AREA)
- AIDS & HIV (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Az (I) általánős képletű vegyületek - a képletben n értéke 0, 1 vagy 2; m értéke 1 vagy 2, azzal a megkötéssel, hőgy ha m értéke 2, akkőr nértéke 1; X jelentése kővalens kötés, -O-, -S- vagy -NR3-; =Q jelentése =O vagy =NR3; R1 jelentése Ar1-, Ar1-(1-6 szénatőmős)alkil- vagy di(Ar1)-(1-6szénatőmős)alkil-csőpőrt, ahől az 1-6 szénatőmős alkilcsőpőrtők adőttesetben szűbsztitűáltak; R2 jelentése Ar2-, Ar2-(1-6 szénatőmős)alkil-, Het- vagy Het-(1-6szénatőmős)alkil-csőpőrt; L jelentése (A) vagy (B) általánős képletű csőpőrt; Ar1 jelentése adőtt esetben szűbsztitűált fenilcsőpőrt; Ar2 jelentése naftilcsőpőrt vagy adőtt esetben szűbsztitűáltfenilcsőpőrt; és Het jelentése adőtt esetben szűbsztitűált egygyűrűs vagy kétgyűrűsheterőciklűsős csőpőrt - tachikinin-antagőnista aktivitásűkkövetkeztében gyógyszerkészítmények hatóanyagaként alkalmazhatók.Ismertetik a fenti vegyületek és ezeket tartalmazó gyógyászatikészítmények előállítását is. (I) (A) <N (B) ŕ
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP95203650 | 1995-12-27 | ||
EP95203653 | 1995-12-27 | ||
PCT/EP1996/005877 WO1997024350A1 (en) | 1995-12-27 | 1996-12-20 | N-acyl-2-substituted-4-(benzimidazolyl- or imidazopyridinyl-substituted residues)-piperidines as tachykinin antagonists |
Publications (3)
Publication Number | Publication Date |
---|---|
HUP9903987A2 true HUP9903987A2 (hu) | 2000-05-28 |
HUP9903987A3 HUP9903987A3 (en) | 2002-01-28 |
HU227799B1 HU227799B1 (hu) | 2012-03-28 |
Family
ID=26139977
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9903987A HU227799B1 (hu) | 1995-12-27 | 1996-12-20 | Tachikinin-antagonista hatású N-acil-2-szubsztituált-4-(benzimidazolil-vagy imidazo-piridinil-szubsztituált csoport)-piperidin-származékok |
Country Status (27)
Country | Link |
---|---|
US (1) | US6110939A (hu) |
EP (1) | EP0869955B1 (hu) |
JP (1) | JP4177895B2 (hu) |
KR (1) | KR100439846B1 (hu) |
CN (1) | CN1117090C (hu) |
AR (1) | AR005279A1 (hu) |
AT (1) | ATE207484T1 (hu) |
AU (1) | AU707116B2 (hu) |
BR (1) | BR9612326A (hu) |
CA (1) | CA2238816C (hu) |
CZ (1) | CZ294199B6 (hu) |
DE (1) | DE69616379T2 (hu) |
DK (1) | DK0869955T3 (hu) |
EA (1) | EA001247B1 (hu) |
ES (1) | ES2166915T3 (hu) |
HK (1) | HK1012187A1 (hu) |
HU (1) | HU227799B1 (hu) |
MY (1) | MY121580A (hu) |
NO (1) | NO313291B1 (hu) |
NZ (1) | NZ325839A (hu) |
PL (1) | PL184489B1 (hu) |
PT (1) | PT869955E (hu) |
SI (1) | SI0869955T1 (hu) |
SK (1) | SK283533B6 (hu) |
TR (1) | TR199801218T2 (hu) |
TW (1) | TW429256B (hu) |
WO (1) | WO1997024350A1 (hu) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5889006A (en) * | 1995-02-23 | 1999-03-30 | Schering Corporation | Muscarinic antagonists |
TW531537B (en) * | 1995-12-27 | 2003-05-11 | Janssen Pharmaceutica Nv | 1-(1,2-disubstituted piperidinyl)-4-substituted piperidine derivatives |
AU7788500A (en) * | 1999-10-25 | 2001-05-08 | Janssen Pharmaceutica N.V. | Use of substance p antagonists for influencing the circadian timing system |
JO3429B1 (ar) | 2001-08-13 | 2019-10-20 | Janssen Pharmaceutica Nv | مشتقات برميدينات مثبطة فيروس الايدز |
US8101629B2 (en) | 2001-08-13 | 2012-01-24 | Janssen Pharmaceutica N.V. | Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile |
DE60231351D1 (de) | 2001-11-23 | 2009-04-09 | Janssen Pharmaceutica Nv | Verwendung von Histaminrezeptorantagonisten für die Senkung des intrakranialen Druckes |
US20040063744A1 (en) * | 2002-05-28 | 2004-04-01 | Tao Wang | Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides |
US7348337B2 (en) | 2002-05-28 | 2008-03-25 | Bristol-Myers Squibb Company | Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides |
AR044152A1 (es) * | 2003-05-09 | 2005-08-24 | Bayer Corp | Derivados de alquilarilo, metodo de preparacion y uso para el tratamiento de la obesidad |
JO2676B1 (en) | 2004-04-06 | 2012-06-17 | جانسين فارماسوتيكا ان. في | Derivatives of second-aza-spiro- (5,4) -dikan and their use as antihistamines |
US20060100432A1 (en) | 2004-11-09 | 2006-05-11 | Matiskella John D | Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione |
ES2346147T3 (es) | 2005-03-03 | 2010-10-11 | Janssen Pharmaceutica Nv | Derivados de oxa-diaza-espiro-(5.5)-undecanona sustituidos y su uso como antagonistas de las neuroquininas. |
JP5078869B2 (ja) | 2005-03-08 | 2012-11-21 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | ニューロキニン(nk1)拮抗物質としてのジアザ−スピロ−[4.4]−ノナン誘導体 |
US7807671B2 (en) | 2006-04-25 | 2010-10-05 | Bristol-Myers Squibb Company | Diketo-piperazine and piperidine derivatives as antiviral agents |
WO2008090114A1 (en) | 2007-01-24 | 2008-07-31 | Glaxo Group Limited | Pharmaceutical compositions comprising 2-methoxy-5- (5-trifluoromethyl-tetrazol-i-yl-benzyl) - (2s-phenyl-piperidin-3s-yl-) |
KR20090035279A (ko) * | 2007-10-05 | 2009-04-09 | 경희대학교 산학협력단 | 위장관 손상 예방 및 치료용 조성물 |
PT2984073T (pt) | 2013-02-08 | 2019-01-21 | Gen Mills Inc | Produto alimentar com baixo teor de sódio |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PH23995A (en) * | 1984-01-09 | 1990-02-09 | Janssen Pharmaceutica Nv | 4((bicycle heterocyclyl)-methyl and hetero)piperidines |
US4695575A (en) * | 1984-11-13 | 1987-09-22 | Janssen Pharmaceutica, N.V. | 4-[(bicycle heterocyclyl)-methyl and -hetero]-piperidines |
US4835161A (en) * | 1986-02-03 | 1989-05-30 | Janssen Pharmaceutica N.V. | Anti-histaminic compositions containing n-heterocyclyl-4-piperidinamines |
EP0232937B1 (en) * | 1986-02-03 | 1992-08-19 | Janssen Pharmaceutica N.V. | Anti-histaminic compositions containing n-heterocyclyl-4-piperidinamines |
NZ223654A (en) * | 1987-03-09 | 1990-03-27 | Janssen Pharmaceutica Nv | 1-alkyl-substituted-benzimidazole-4-piperidinamines and pharmaceutical compositions |
US4943580A (en) * | 1987-03-09 | 1990-07-24 | Janssen Pharmaceutica N.V. | Anti-histaminic benzimidazole, imidazopyridine and purine derivatives |
TW397831B (en) * | 1994-07-15 | 2000-07-11 | Meiji Seika Kaisha | The anti-platelet-agglutination hexahydrogenated pyridine and its derivatives |
US5935951A (en) * | 1994-09-30 | 1999-08-10 | Novartis Finance Corporation | 1-acyl-4-aliphatylaminopiperidine compounds |
NZ321575A (en) * | 1995-10-30 | 1999-05-28 | Janssen Pharmaceutica Nv | 1-(1,2-disubstituted piperidinyl)-4- substituted piperazine derivatives |
-
1996
- 1996-12-13 TW TW085115389A patent/TW429256B/zh not_active IP Right Cessation
- 1996-12-20 ES ES96944686T patent/ES2166915T3/es not_active Expired - Lifetime
- 1996-12-20 NZ NZ325839A patent/NZ325839A/xx not_active IP Right Cessation
- 1996-12-20 PT PT96944686T patent/PT869955E/pt unknown
- 1996-12-20 JP JP52402997A patent/JP4177895B2/ja not_active Expired - Fee Related
- 1996-12-20 CZ CZ19981866A patent/CZ294199B6/cs not_active IP Right Cessation
- 1996-12-20 TR TR1998/01218T patent/TR199801218T2/xx unknown
- 1996-12-20 EP EP96944686A patent/EP0869955B1/en not_active Expired - Lifetime
- 1996-12-20 HU HU9903987A patent/HU227799B1/hu not_active IP Right Cessation
- 1996-12-20 AT AT96944686T patent/ATE207484T1/de active
- 1996-12-20 BR BR9612326A patent/BR9612326A/pt not_active IP Right Cessation
- 1996-12-20 AU AU13080/97A patent/AU707116B2/en not_active Ceased
- 1996-12-20 DK DK96944686T patent/DK0869955T3/da active
- 1996-12-20 SI SI9630394T patent/SI0869955T1/xx unknown
- 1996-12-20 PL PL96327440A patent/PL184489B1/pl unknown
- 1996-12-20 SK SK829-98A patent/SK283533B6/sk unknown
- 1996-12-20 WO PCT/EP1996/005877 patent/WO1997024350A1/en active IP Right Grant
- 1996-12-20 KR KR10-1998-0704829A patent/KR100439846B1/ko not_active IP Right Cessation
- 1996-12-20 EA EA199800602A patent/EA001247B1/ru not_active IP Right Cessation
- 1996-12-20 DE DE69616379T patent/DE69616379T2/de not_active Expired - Lifetime
- 1996-12-20 CN CN96199406A patent/CN1117090C/zh not_active Expired - Fee Related
- 1996-12-20 CA CA002238816A patent/CA2238816C/en not_active Expired - Fee Related
- 1996-12-26 AR ARP960105896A patent/AR005279A1/es active IP Right Grant
- 1996-12-26 MY MYPI96005483A patent/MY121580A/en unknown
-
1998
- 1998-05-27 NO NO19982406A patent/NO313291B1/no not_active IP Right Cessation
- 1998-06-19 US US09/102,121 patent/US6110939A/en not_active Expired - Lifetime
- 1998-12-15 HK HK98113363A patent/HK1012187A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP9903987A2 (hu) | Tachikinin-antagonista hatású N-acil-2-szubsztituált-4-(benzimidazolil-vagy imidazo-piridinil-szubsztituált csoport)-piperidin -származékok | |
AR036027A2 (es) | Un compuesto heterociclico substituido, procedimiento y compuestos intermediarios para su preparacion y composicion farmaceutica que contiene a dicho compuesto | |
FR2674851B1 (fr) | Derives s-triaziniques portant des substituants benzylidene camphre, compositions cosmetiques filtrantes et leur utilisation pour proteger la peau et les cheveux du rayonnement ultraviolet. | |
NZ515664A (en) | Benzimidazole derivatives useful as respiratory syncytial virus replication inhibitors | |
RU2000113595A (ru) | Производные пиридонкарбоновой кислоты или его соль | |
NO177424C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive N-(4-piperidinyl)(dihydrobenzofuran- eller dihydro-2H-benzopyran)karboksamidderivater samt mellomprodukter | |
CO4990959A1 (es) | Isoquinolinas | |
FI925801A0 (fi) | Piperidyl-substituerade indoler | |
AU6802490A (en) | Novel 2-substituted 4-(3-alkyl-5-tert.-butyl-4-hydroxyphenyl)thiazoles, processes for their preparation, pharmaceuticals containing them and their use | |
IL106993A (en) | Benzenalkanoic acid derivatives and pharmaceutical compositions containing them | |
ATE25689T1 (de) | 5-0-mycaminosyl-tylonolide derivate, modifiziert an position c-23. | |
DE69310567T2 (de) | In der 3-Position durch einen gesättigten oder ungesättigten Fettsäurerest substituierte Pyrrolidinderivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel mit Thromboxan-A2 inhibierender Aktivität | |
ATE73123T1 (de) | Neue 3,5-dihydroxycarbonsaeuren und deren derivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate und zwischenprodukte. | |
DK0581849T3 (da) | Thiocarbamat-sulfoxidholdigt præparat til afskræmning fra ethanolindtagelse | |
ATE510828T1 (de) | S-triazinverbindungen besitzend zwei substituenten ausgewählt aus der gruppe von sperrigen para-aminobenzalmalonat- und para- aminobenzalmalonamidgruppen und einem aminobenzoatesubstituenten, deren zusammensetzungen und verwendungen. | |
NO974747L (no) | Fremgangsmåte for fremstilling av streptograminer | |
NL7505473A (nl) | Werkwijze voor het bereiden van pyroglutamylver- bindingen met antidepressieve werking. | |
HUP9903810A2 (hu) | Ciklopeptidszármazékok | |
DE69125248T2 (de) | Gerät zum Steuern des Kraftstoffeinspritzzeitpunktes eines Diesel-Motors | |
CA2019005A1 (en) | Antiherpes pentapeptide derivatives having a cycloalkyl substituted aspartic acid side chain |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of definitive patent protection due to non-payment of fees |